Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
NCT: NCT05796453 · COMPLETED
NCT IDNCT05796453
StatusCOMPLETED
Start Date2023-09-19
Completion2026-08-21
SponsorAlcon Research (INDUSTRY)
First posted
Last updated
Brief Summary
The purpose of this Post-Market Clinical Follow-up study is to describe the long-term safety and performance of the Clareon Vivity and Vivity Toric and Clareon PanOptix and PanOptix Toric IOLs.
Frequently Asked Questions
What is Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix?
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix is a clinical trial registered under NCT05796453. Current status: COMPLETED.
What is the status of NCT05796453?
The current status of NCT05796453 (Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix) is: COMPLETED.
When did Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix start?
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix started on 2023-09-19.
Related Devices
K161794CENTURION Vision System (Active SentryTM)Alcon Research, Ltd.
K170520HyperVit Vitrectomy Probe, 23 GA, HyperVit Vitrectomy Probe, 25+, HyperVit Vitrectomy Probe, 27+Alcon Research, Ltd.
K191650LEGION SystemAlcon Research, LLC
PMA P040020Lens, multifocal intraocularAlcon Research, Ltd.
PMA P150037Intraocular pressure lowering implantAlcon Research, Ltd.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.